Wells Fargo & Company Zai Lab LTD Transaction History

Wells Fargo & Company

$410 Billion
Q1 2024

A detailed history of Wells Fargo & Company transactions in Zai Lab LTD stock. As of the latest transaction made, Wells Fargo & Company holds 500 shares of ZLAB stock, worth $8,665. This represents 0.0% of its overall portfolio holdings.

Number of Shares

500

Holding current value

$8,665

% of portfolio

0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$15.95 - $26.8 $7,975 - $13,400	500 New	500 $8,000
Q3 2023 Nov 13, 2023	BUY	$22.72 - $31.49 $3,203 - $4,440	141 New	141 $3,000
Q1 2023 May 12, 2023	BUY	$30.21 - $48.1 $694 - $1,106	23 New	23 $0
Q3 2022 Nov 14, 2022	SELL	$34.2 - $51.69 $28,112 - $42,489	-822 Reduced 45.12%	1,000 $34,000
Q2 2022 Aug 12, 2022	BUY	$23.14 - $49.68 $763 - $1,639	33 Added 1.84%	1,822 $64,000

Q1 2022 May 16, 2022	SELL	$27.77 - $64.4 $1,305 - $3,026	-47 Reduced 2.56%	1,789 $79,000
Q4 2021 Feb 14, 2022	SELL	$54.9 - $105.21 $16.6 Million - $31.8 Million	-301,841 Reduced 99.4%	1,836 $116,000
Q3 2021 Nov 15, 2021	SELL	$105.0 - $178.37 $28.8 Million - $48.9 Million	-274,414 Reduced 47.47%	303,677 $32 Million
Q2 2021 Aug 16, 2021	BUY	$125.11 - $180.0 $1.67 Million - $2.4 Million	13,309 Added 2.36%	578,091 $102 Million
Q1 2021 May 13, 2021	BUY	$126.27 - $191.71 $1.58 Million - $2.4 Million	12,508 Added 2.26%	564,782 $75.4 Million
Q4 2020 Feb 09, 2021	BUY	$81.94 - $135.34 $970,005 - $1.6 Million	11,838 Added 2.19%	552,274 $74.7 Million
Q3 2020 Nov 05, 2020	BUY	$73.3 - $89.48 $6.89 Million - $8.41 Million	94,021 Added 21.06%	540,436 $44.9 Million
Q2 2020 Aug 13, 2020	SELL	$48.82 - $82.53 $6.23 Million - $10.5 Million	-127,628 Reduced 22.23%	446,415 $36.7 Million
Q1 2020 May 14, 2020	BUY	$39.1 - $62.9 $22.4 Million - $36.1 Million	574,043 New	574,043 $29.6 Million

Others Institutions Holding ZLAB

# of Institutions

124

Shares Held

39.9M

Call Options Held

41.2K

Put Options Held

190K

Wellington Management Group LLP Boston, MA

6.66M
Shares

$115 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

5.68M
Shares

$98.5 Million
0.02% of portfolio
Janus Henderson Group PLC London, X0

4.43M
Shares

$76.7 Million
0.04% of portfolio
Woodline Partners LP San Francisco, CA

2.6M
Shares

$45 Million
0.4% of portfolio
Viking Global Investors LP

2.05M
Shares

$35.5 Million
0.12% of portfolio

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $1.7B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account